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Propofol Waste Reduction in the Operating Room
Abstract
Propofol is the most wasted intravenous medication used in anesthesia in the operating room (OR) (More,
Dabhade, & Ghongane, 2015). Propofol, a sedative anxiolytic, is utilized as a continuous infusion in
sedation procedures, or monitored anesthesia care (Nagelhout & Elisha, 2014). Inherent to these
infusions is unpredictability in determining the amount of medication needed for the duration of a
procedure. This project implemented customized propofol preparation charts consistent with the
literature to aid the administering professional in determining the approximate milliliter requirement for
the duration of a procedure. The pre-intervention steps consisted of voluntary data collection among
anonymous anesthesia professionals in the OR regarding infusion characteristics. Patient weight, a
commonly used infusion rate, and the duration of procedure were used in the calculation within
customized charts. Post-intervention data collection was conducted in the same manner to capture the
impact of the charts. This data was measured simultaneously at a local healthcare system’s main
hospital and separate surgery center site, and waste reduction from baseline data was found to be 49%
and 60%, respectively. This project was conducted over a four-month period and translates to a potential
yearly savings of greater than $15,000 for the healthcare system. A culture of waste reduction leads to
savings for anesthesia departments and healthcare organizations as a whole.
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Abstract
Propofol is the most wasted intravenous medication used in anesthesia in the operating room
(OR) (More, Dabhade, & Ghongane, 2015). Propofol, a sedative anxiolytic, is utilized as a
continuous infusion in sedation procedures, or monitored anesthesia care (Nagelhout & Elisha,
2014). Inherent to these infusions is unpredictability in determining the amount of medication
needed for the duration of a procedure. This project implemented customized propofol
preparation charts consistent with the literature to aid the administering professional in
determining the approximate milliliter requirement for the duration of a procedure. The preintervention steps consisted of voluntary data collection among anonymous anesthesia
professionals in the OR regarding infusion characteristics. Patient weight, a commonly used
infusion rate, and the duration of procedure were used in the calculation within customized
charts. Post-intervention data collection was conducted in the same manner to capture the impact
of the charts. This data was measured simultaneously at a local healthcare system’s main hospital
and separate surgery center site, and waste reduction from baseline data was found to be 49%
and 60%, respectively. This project was conducted over a four-month period and translates to a
potential yearly savings of greater than $15,000 for the healthcare system. A culture of waste
reduction leads to savings for anesthesia departments and healthcare organizations as a whole.
Keywords: propofol, operating room, waste reduction, intravenous medication
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Propofol Waste Reduction in the Operating Room
Waste of intravenous medications is a global issue, costing institutions billions of dollars
each year. The majority of intravenous medication waste in hospitals is attributed to common
agents utilized in anesthesia care in the operating room (OR) (Dee, 2012). Propofol is
consistently associated with the most waste of these medications (More et al., 2015). Factors
leading to propofol waste include variable vial sizes, duration of procedures, multiple pump
tubing types, and patient requirements. These factors vary in severity between institutions, but
the evidence has demonstrated that reduction of propofol waste saving thousands of dollars is
realistically achievable.
Implementation of customized propofol preparation charts guide the anesthesia
professional in selecting the approximate number and size of propofol vials for anesthetic
delivery. Specifically, these charts incorporate an institution’s stocked vial sizes, predominant
dosing strategy, patient weight, and the duration of the procedure. This is used to calculate the
approximate milliliter (mL) requirement for any anesthetic utilizing a propofol infusion.
Implementing these evidence-based charts at a local healthcare system’s main hospital and
surgery center has the potential to significantly reduce propofol waste and demonstrate savings
consistent with the literature.
Background and Significance
Available Knowledge
Prescription drug expenditures in US hospitals have risen to more than $32 billion
annually, with an estimated $1 billion in medication waste according to Toerper et al. (2014).
Internationally, Canada approximates $8 billion in intravenous medication waste annually, while
the United Kingdom approximates $300 million (AlSamanhodi et al., 2017). These numbers
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translate to annual hospital wastage rates between 16.6% and 28.7% (Toerper et al., 2014). The
predominant reason for intravenous medication waste in the OR is the need to dispose of full or
partially full syringes by anesthesia professionals due to case completion, contamination, or
expiration (Roberman, Ahmad, & Green, 2015). It is important to note that the anesthesia drug
budget in the OR is responsible for 5-15% of a hospital’s total pharmacy budget, making it a
“ripe target for decreasing waste, increasing efficiency, and improving the bottom line”
(Atcheson, Spivack, Williams, & Bryson, 2016, p. 25).
Propofol is associated with the most waste among medications administered by
anesthesia personnel in the OR (More et al., 2015). It has been reported that propofol was both
the most dispensed and wasted medication for 45% of medication waste at a surgical suite
(Mankes, 2012). Propofol is a sedative anxiolytic commonly used for the induction of general
anesthesia, as an infusion for total intravenous anesthesia (TIVA), or as a sedation infusion for
less invasive monitored anesthesia care (MAC) (Naglehout, 2014). The use of propofol infusions
for sedation is of particular significance due to difficulty in accurately gauging how much
propofol will be required. The number and size of the vials selected to prepare or add to an
existing infusion can be unpredictable due to patient differences and varying durations of
procedures. Propofol is consequently notable for as much as 51% waste of what is prepared, with
a mean waste of 5.4 mL per case (Roberman et al., 2015; Dee, 2012).
Propofol waste is less of an issue in the induction of general anesthesia because it is
typically administered at a maximum of a 20 mL bolus from one 20 mL vial. Cost rises for TIVA
cases as higher doses of propofol infusions are used to achieve general anesthesia, typically
utilizing larger vial sizes such as 50 or 100 mL (Rinehardt & Sivarajan, 2012). Sedation, or
MAC, cases pose highly variable waste data due to a lighter anesthetic plane requiring variable
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dosage adjustments depending on the patient response, nature of the procedure, and remaining
duration of the procedure. Time remaining in a procedure can be difficult to ascertain and leads
to more waste if the professional opens another vial they may not need. MAC case waste may
see the most reduction benefit through the utilization of a customized propofol preparation chart
that incorporates these factors.
Two institutions, Cincinnati Children’s Hospital Medical Center and Madigan Army
Medical Center, implemented their own customized propofol charts in the form of a quality
improvement project. Cincinnati Children’s reduced its propofol waste by 50% with savings of
$2,500 per month over a three-month period (Gordon & Varaghese, 2016). Madigan Army
Medical Center completed a longer cycle of six months and reported median waste volume per
case decline from 45.6 to 14.3 mL, or a 68% reduction (Kicker, Hill, & Matheson, 2018).
Rationale and Context
A local healthcare system was challenged with reducing its propofol waste similar to the
previously discussed institutions. Its main hospital currently utilizes propofol infusions for
sedation more than 4,000 times each year, with 4,225 cases between August 2018 and July 2019.
This equates to at least 300 opportunities to reduce waste each month at its main campus. In
addition, the healthcare system’s primary surgery center was added as a second site after the
medical director learned of the project at the main hospital. This surgery center performs a
monthly average of over 700 surgical procedures with anesthesia and utilizes propofol infusions
in 150-200 of those anesthetics. The implementation of propofol preparation charts at these sites
will create ample opportunity to decrease preventable waste and increase savings.
Project Aims
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The aim of this project is to decrease baseline propofol infusion waste by 50% with the
implementation of the customized propofol preparation chart at two sites within a local
healthcare system. Cost savings will be calculated from total waste reduction at each site. This
aim is aligned with the goal of similar projects previously discussed in this paper.
Methods
Intervention
Propofol preparation charts and information sheets were placed in every OR along with
extra copies in the anesthesia break room during the intervention phase. These tools were
individualized to common adult weights in kilograms, dosing, and duration of procedures in
minutes to guide anticipated milliliter requirement (see Figure 1 and Figure 2). These institutions
supply 10, 20, and 50 mL vials of propofol, thus the milliliter requirement guided clinician
judgement in vial size selection.
The customized tool was modeled after Kicker et al.’s (2018) propofol preparation charts
that incorporate a 150 or 250 mcg/kg/min dosing strategy, case duration in minutes, and patient
weight. Education about the tool and project goals was presented via PowerPoint to anesthesia
staff at three in-person departmental meetings and via email. Data before and after
implementation were collected on paper voluntarily by anonymous participation of all anesthesia
professionals including physician anesthesiologists, certified registered nurse anesthetists,
student registered nurse anesthetists, and anesthesia residents. The primary data recorded
included the amount of propofol prepared, the amount administered, and the amount wasted in
mL. Demographic data of providers was not collected to encourage participation and preserve
anonymity. Thus, the data solely examined individual propofol infusion characteristics.
Study of Intervention
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Data collection was conducted for a total period of 16 weeks across all ORs at the
healthcare system’s main hospital. Eight weeks of baseline data were collected prior to
intervention implementation followed by another eight weeks after implementation. Data
collection also occurred at the hospital’s surgery center for ten weeks across all ORs. This data
collection was for five weeks prior to and five weeks following implementation. The surgery
center site was added at a later date than the main hospital, hence the difference in data collection
timelines. The two sites were analyzed separately due to significantly different propofol cost
between them.
This project utilized a descriptive nonequivalent posttest-only control group design. This
design consists of one experimental group that receives an intervention, known as the
independent variable, and one control group that receives either no intervention or a placebo. The
control group, or pre-intervention period, consisted of sedation cases prior to the intervention and
the experimental group, or post-intervention period, included sedation cases after implementation
of the intervention. The outcome of interest was total amount of propofol wasted per procedure
in mL. The study population was derived from a convenience sample during each phase of data
collection. The inclusion criterion was any sedation procedure in the OR utilizing a propofol
infusion as the anesthetic. Exclusion criteria were any procedure done under general anesthesia,
any sedation procedure that required conversion to general anesthesia, and any sedation
procedure in which the patient did not receive propofol as a continuous infusion.
Measures
This project measured one dichotomous independent variable, two continuous primary
outcomes, and four additional variables. The independent variable was the placement of a chart
in each OR to provide decision support to anesthesia professionals on how much propofol to
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prepare in mL, with no chart present for the pre-intervention period. The primary outcomes were
the amount of propofol wasted in each procedure and the cost of this wasted medication. Other
variables included the amount of propofol administered, the primary propofol infusion dose,
patient weight, and the duration of the procedure.
Analysis
The Shapiro-Wilk W test was used to test the normality of all continuous variables
(Grove & Cipher, 2017a). The primary outcome was measured with Student’s t test, also known
as the independent samples t-test, if the outcome variable was parametric (Grove & Cipher,
2017b). The Mann-Whitney U test was used if the outcome variable was nonparametric (Grove
& Cipher, 2017c). The independent samples t-test or Mann-Whitney U test were similarly
utilized to measure whether the remaining variables were the same or significantly different
between the pre-intervention and post-intervention periods.
Ethical Considerations
There were no ethical issues identified during the conduction of this project. Institutional
review board exempt status for quality improvement at both the authors’ university and the
institution where the project was conducted was secured prior to the initiation of data collection.
The authors report no conflicting interests and will not personally benefit from the outcome of
the project. The authors would like to acknowledge the time taken by anesthesia personnel at
both the trauma center’s main hospital and its surgery center for taking the time to record data.
Results
The main hospital had a sample size of 101 and 51 cases before and after the
intervention, respectively. The data for propofol waste was determined to be nonparametric both
before and after the intervention based on the Shapiro Wilk test (p = .007 and p < .001,
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respectively). The Mann-Whitney U test determined that there was a statistically significant
difference before and after the intervention (p < .001). The main hospital had a median waste of
27 mL per case pre-intervention, with an interquartile range (IQR) of 15.3-39.6 mL wasted each
case. This decreased to a median of 13.8 mL per case after the intervention, with an IQR of 4-20
mL. This represents a median savings of $3.70 per case, with an IQR of $3.16-5.49. This
intervention has the potential to reduce waste in over 300 cases each month and over 4,000 cases
each year, representing a possible monthly savings of $1,143 and a potential yearly savings of
$15,240 based on the median difference.
The variables patient weight, primary propofol infusion dose, amount of propofol
administered, and duration of the procedure were also analyzed for normality via the Shapiro
Wilk test. Patient weight was the only variable determined to have a parametric distribution.
There were no significant differences in these variables between the pre-intervention and postintervention periods. These variables, as well as the sample sizes and median wastes, are
presented in Table 1.
The second site, the surgery center, had a sample size of 70 and 64 cases before and after
the intervention, respectively. The data for propofol waste was determined to be nonparametric
for both before and after the intervention based on the Shapiro Wilk test (p < .001 for both). The
Mann-Whitney U test determined that there was a statistically significant difference before and
after the intervention (p = .001). The surgery center had a median waste of 10 mL per case preintervention, with an IQR of 0-20.3 mL wasted each case. This decreased to a median of 4 mL
per case after the intervention, with an IQR of 0-8 mL. This represents a median savings of $0.19
per case, with an IQR of $0-0.39. This intervention has the potential to reduce waste in 150-200
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cases each month, representing a possible monthly savings of $28.50-38 and a potential yearly
savings of $342-456 based on the median difference.
The variables patient weight, primary propofol infusion dose, amount of propofol
administered, and duration of the case were analyzed for normality via the Shapiro Wilk test.
None of the variables were determined to have a parametric distribution. There were no
significant differences between the pre-intervention and post-intervention period for patient
weight and the amount of propofol administered. The primary propofol infusion dose had a
median rate of 100 (IQR = 100-150) and 150 (IQR = 125-200) mcg/kg/min before and after the
intervention, respectively (p < .001). The median duration per case prior to the intervention was
68 minutes (IQR = 45-92.5) and 42 minutes (IQR = 30-67.5) after implementation (p < .001).
These variables, as well as sample sizes and median wastes, are presented in Table 2.
Discussion
Summary
Excessive waste of propofol in sedation procedures negatively impacts the anesthesia
medication budget and subsequently its organization. Uncertainty in preparation can be
eliminated and waste per case markedly reduced by implementing a tool that estimates the
amount of propofol needed for a procedure. The results of this project demonstrate the success of
such an intervention as a significant difference in waste was observed. Propofol preparation chart
utilization effectively reduced waste by 60% at the surgery center site, exceeding the goal of
50% waste reduction. The main hospital site nearly met the goal at 49%. This reduction
represents both a statistically and clinically significant waste reduction in comparison with other
healthcare systems reporting a reduction of 50% or higher. The main hospital site utilizes
propofol infusions for sedation cases more than 4,000 times each year and there is huge potential
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for ongoing cost savings with a sustained culture change among professionals. The same applies
to the surgery center site. There were no differences between observed and expected outcomes.
There was not a significant difference between any of the other pre and post variables
collected at the main hospital. The surgery center did have two significant differences pre- and
post-intervention. One of these variables was propofol infusion rate, which significantly
increased after implementation of the intervention. The increase in propofol infusion rate may
have contributed to a decrease in propofol waste by allowing propofol to be more rapidly
infused, causing an increase in administration. The other variable was case duration, which
significantly decreased after implementation of the intervention. The decrease in case duration
may have contributed to an increase in propofol waste due to there being less time for prepared
propofol to be administered during the procedure. These significant differences may have
canceled each other out. Thus, it is unlikely that these differences made a significant impact on
the amount of propofol wasted.
Success of the propofol preparation charts was due to the ease of creation and
customization utilizing a simple table format and calculation of incremental weight ranges
against time in minutes at a constant dose. The authors made two customized charts for this
project based on the most common doses used by the healthcare system’s professionals, 100
mcg/kg/min and 150 mcg/kg/min. These charts also have the flexibility to be adjusted for any
dose and can be reproduced many times depending on the user’s need. The fact that these charts
were printed on paper and placed in the OR also created an ease of distribution to professionals,
as well as overall low cost of implementation. Strengths of this project included the use of the
two sites, an overall high level of voluntary anesthesia professional participation, and adequate
sample sizes.
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Interpretation
The decline in waste was comparable to similar approaches conducted at Cincinnati
Children’s Hospital and Madigan Army Medical Center. The total project cycle lasted four
months, while the other studies conducted cycles of three and six months, respectively. Both of
these similar studies reported waste reduction at or exceeding the goal of 50%. An important
distinction of this project is that the authors were able to measure, replicate, and compare the
results of two sites simultaneously within one health system. This indicates the versatility and
transferability of the propofol charts in decreasing waste at any site.
Limitations
This project was not without limitations despite its success. The authors used just one
healthcare system. Another limitation arose from the use of convenience sampling rather than
random sampling for data collection. Certain professionals may have been more or less likely to
participate depending on their personal perception of waste.
Tubing type for infusion administration was another limitation, as it was not
standardized. This created variability in priming volumes with syringe pump tubing using a
priming volume of approximately 4 mL and macrodrip pump tubing using approximately 20 mL.
The project also lacked professional demographic information. This was done intentionally to
encourage anonymity and participation, yet trends among anesthesiologists, certified registered
nurse anesthetists, students, and residents could have been further evaluated.
Some difficulties arose with the paper format utilized for data collection. The paper
sheets for data collection and with the charts had the potential to be lost if thrown away or
misplaced. Any missing data could increase or decrease the calculated total waste reduction.
Weekly audits were conducted to minimize the effect of this issue. There was a small period of
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time when participation slowed but subsequently increased following a department-wide email.
The lack of a secure location, such as in the electronic health record for example, may have
contributed to some lapses in data collection participation.
Conclusion
Propofol waste reduction directly translates to cost savings, which is a large incentive to
keep this project sustainable not only in the local institution but also in any institution utilizing
propofol infusions. Potential future modifications to the intervention to ensure this include
modeling the propofol preparation charts directly into the electronic medical record with an
interface for any dose to calculate and suggest to the provider the amount of drug needed in real
time. An electronic tool could also take this a step further and suggest the best combination and
quantity of differing vial sizes for quick selection. This would remain a relatively low-cost
approach to saving an anesthesia department, and its institution, money that could be better
utilized elsewhere.
Recommendations for research and quality improvement include conducting similar
inquiry over a longer period of time to assess financial impact on a larger scale. This will create
opportunities for interdisciplinary collaboration and aid in an institution’s shift to Value-Based
Care, or the practice of producing the best possible outcomes at the lowest possible cost (Harris,
Carney, & Volpicelli, 2017). This approach could also be translated to other medications
demonstrating high levels of waste in an institution with a preparation tool tailored to the drug’s
profile.
This project demonstrated the practicality and usefulness of the propofol preparation
charts. These charts provided a simple, low cost tool to reduce waste of the highest wasted
medication in the OR, propofol. Next steps include replication of the process over more cycles
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and at more healthcare systems. A culture of saving can arise amongst anesthesia professionals
and their organizations by fostering awareness of current waste and the evidence that its
reduction is achievable.
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Table 1
Primary Results at the Main Hospital
Project Variables

Pre-Intervention Post-Intervention P-Value

Sample Size

101

51

N/A

Mean Patient Weight in kg

82

82.3

.944

Median Primary Propofol Infusion Dose in

100 [75-125]

100 [75-130]

.480

51.7 [39.1-81.5]

50 [38-81]

.977

Median Duration of Each Case in min

72 [40-108]

60 [40-92]

.449

Median Propofol Waste Per Case in mL

27 [15.3-39.6]

13.8 [4-20]

< .001

mcg/kg/min
Median Amount of Propofol Administered
Per Case in mL

Note. Interquartile ranges are in brackets. N/A = not applicable. P-values refer to Mann-Whitney
U tests for medians and t-tests for means.
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Table 2
Primary Results at the Surgery Center
Project Variables

Pre-Intervention Post-Intervention P Value

Sample Size

70

64

N/A

Median Patient Weight in kg

76.5 [65.2-90.7]

79.4 [67-93.8]

.572

Median Primary Propofol Infusion Dose in

100 [100-150]

150 [125-200]

< .001

67.8 [37.3-95.5]

50 [28.8-90.8]

.140

Median Duration of Each Case in min

68 [45-92.5]

42 [30-67.5]

< 0.01

Median Propofol Waste Per Case in mL

10 [0-20.3]

4 [0-8]

.001

mcg/kg/min
Median Amount of Propofol Administered
Per Case in mL

Note. Interquartile ranges are in parentheses. N/A = not applicable. P-values refer to MannWhitney U tests.
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Figure 1. Propofol preparation chart based on a propofol infusion dose of 100 mcg/kg/min.
Patient weight is listed in the leftmost column in 5 kg increments from 50 to 100 kg, then in 10kilogram increments from 100 to 120 kg. Time is in the topmost row in 10 min increments from
10 to 100 min. The non-bolded numbers represent the volume of propofol required in milliliters
to maintain a 100 mcg/kg/min infusion based on patient weight and time.
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Figure 2. Propofol preparation chart based on a propofol infusion dose of 150 mcg/kg/min.
Patient weight is listed in the leftmost column in 5 kg increments from 50 to 100 kg, then in 10
kg increments from 100 to 120 kg. Time is in the topmost row in 10 min increments from 10 to
100 min. The non-bolded numbers represent the volume of propofol required in milliliters to
maintain a 150 mcg/kg/min infusion based on patient weight and time.

